Xconomy: Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsFebruary 2, 2017M&A, Boston Life Science Ecosystem
Back Bay in Wall Street Journal Newsletter: Biotech M&A Deals Expected to Increase Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsJanuary 17, 2017M&A, Investment Banking, Life Science IPOs
Pfizer To Acquire Medivation: From $1.00 TO $81.50 Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsSeptember 20, 2016M&A
